Literature DB >> 2548322

A competitive inhibition ELISA for the differentiation of serum antibodies from pigs infected with transmissible gastroenteritis virus (TGEV) or with the TGEV-related porcine respiratory coronavirus.

P Callebaut1, M B Pensaert, J Hooyberghs.   

Abstract

A competitive inhibition ELISA was developed to detect non-neutralizing antibodies to the peplomer protein of transmissible gastroenteritis virus (TGEV) in porcine sera using a monoclonal antibody as an indicator. It was demonstrated that field strains of the TGEV-related porcine respiratory coronavirus (PRCV) did not induce this antibody, whereas the Miller strain and field strains of TGEV did. The sensitivity of the competitive inhibition ELISA appeared to be similar to that of the virus neutralization (VN) test. The test enables differentiation of pigs which were previously infected with TGEV or PRCV and which cannot be distinguished by the classical anti-TGEV neutralization test. The present test is useful for selective serodiagnosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548322      PMCID: PMC7117365          DOI: 10.1016/0378-1135(89)90003-5

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  11 in total

1.  Upper respiratory infection of lactating sows with transmissible gastroenteritis virus following contact exposure to infected piglets.

Authors:  L J Kemeny; V L Wiltsey; J L Riley
Journal:  Cornell Vet       Date:  1975-07

2.  New porcine coronavirus?

Authors:  I Brown; S Cartwright
Journal:  Vet Rec       Date:  1986-09-13       Impact factor: 2.695

3.  A transmissible gastroenteritis in pigs.

Authors:  L P DOYLE; L M HUTCHINGS
Journal:  J Am Vet Med Assoc       Date:  1946-04       Impact factor: 1.936

4.  Critical epitopes in transmissible gastroenteritis virus neutralization.

Authors:  G Jiménez; I Correa; M P Melgosa; M J Bullido; L Enjuanes
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  Antigenic variation of porcine transmissible gastroenteritis virus detected by monoclonal antibodies.

Authors:  T Hohdatsu; Y Eiguchi; M Tsuchimoto; S Ide; H Yamagishi; M Matumoto
Journal:  Vet Microbiol       Date:  1987-06       Impact factor: 3.293

6.  Differentiation of porcine coronavirus from transmissible gastroenteritis virus.

Authors:  D J Garwes; F Stewart; S F Cartwright; I Brown
Journal:  Vet Rec       Date:  1988-01-23       Impact factor: 2.695

Review 7.  On the pathogenesis of transmissible gastroenteritis of swine.

Authors:  E O Haelterman
Journal:  J Am Vet Med Assoc       Date:  1972-02-15       Impact factor: 1.936

8.  Isolation of a porcine respiratory, non-enteric coronavirus related to transmissible gastroenteritis.

Authors:  M Pensaert; P Callebaut; J Vergote
Journal:  Vet Q       Date:  1986-07       Impact factor: 3.320

9.  Antigenic structure of transmissible gastroenteritis virus. I. Properties of monoclonal antibodies directed against virion proteins.

Authors:  H Laude; J M Chapsal; J Gelfi; S Labiau; J Grosclaude
Journal:  J Gen Virol       Date:  1986-01       Impact factor: 3.891

10.  Antigenic differentiation between transmissible gastroenteritis virus of swine and a related porcine respiratory coronavirus.

Authors:  P Callebaut; I Correa; M Pensaert; G Jiménez; L Enjuanes
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

View more
  18 in total

1.  Prevalence of coronavirus antibodies in Iowa swine.

Authors:  R D Wesley; R D Woods; J D McKean; M K Senn; Y Elazhary
Journal:  Can J Vet Res       Date:  1997-10       Impact factor: 1.310

2.  Differentiation of transmissible gastroenteritis virus from porcine respiratory coronavirus and other antigenically related coronaviruses by using cDNA probes specific for the 5' region of the S glycoprotein gene.

Authors:  I Bae; D J Jackwood; D A Benfield; L J Saif; R D Wesley; H Hill
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

3.  Three new isolates of porcine respiratory coronavirus with various pathogenicities and spike (S) gene deletions.

Authors:  E M Vaughn; P G Halbur; P S Paul
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

4.  Porcine respiratory coronavirus in Quebec: Serological studies using a competitive inhibition enzyme-linked immunosorbent assay.

Authors:  A Jabrane; Y Elazhary; B G Talbot; R Ethier; C Dubuc; R Assaf
Journal:  Can Vet J       Date:  1992-11       Impact factor: 1.008

5.  Seroconversion of pigs in contact with dogs exposed to canine coronavirus.

Authors:  R D Woods; R D Wesley
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

6.  Pathogenicity of porcine respiratory coronavirus isolated in Québec.

Authors:  A Jabrane; C Girard; Y Elazhary
Journal:  Can Vet J       Date:  1994-02       Impact factor: 1.008

7.  The porcine microRNA transcriptome response to transmissible gastroenteritis virus infection.

Authors:  Xiao Liu; Ling Zhu; Shan Liao; Zhiwen Xu; Yuancheng Zhou
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

8.  Establishment of porcine enterocyte/myofibroblast co-cultures for the growth of porcine rota- and coronaviruses.

Authors:  Tingting Cui; Sebastiaan Theuns; Lowiese M B Desmarets; Jiexiong Xie; Gaëtan M A De Gryse; Bo Yang; Wim Van den Broeck; Hans J Nauwynck
Journal:  Sci Rep       Date:  2018-10-12       Impact factor: 4.379

9.  Evaluation of the Serologic Cross-Reactivity between Transmissible Gastroenteritis Coronavirus and Porcine Respiratory Coronavirus Using Commercial Blocking Enzyme-Linked Immunosorbent Assay Kits.

Authors:  Ronaldo Magtoto; Korakrit Poonsuk; David Baum; Jianqiang Zhang; Qi Chen; Ju Ji; Pablo Piñeyro; Jeffrey Zimmerman; Luis G Giménez-Lirola
Journal:  mSphere       Date:  2019-03-13       Impact factor: 4.389

10.  Role of Porcine Aminopeptidase N and Sialic Acids in Porcine Coronavirus Infections in Primary Porcine Enterocytes.

Authors:  Tingting Cui; Sebastiaan Theuns; Jiexiong Xie; Wim Van den Broeck; Hans J Nauwynck
Journal:  Viruses       Date:  2020-04-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.